References
Dicuonzo F, Salvati A, Palma M, Lefons V, Lasalandra G, De LF et al. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings. J Child Neurol 2009; 24: 1013–1018.
Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC . Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 2008; 19: 178–184.
Haykin M, Gorman M, van HJ, Fulbright R, Baehring J . Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity. J Neurooncol 2006; 76: 153–157.
Bernini JC, Fort DW, Griener JC, Kane BJ, Chappell WB, Kamen BA . Aminophylline for methotrexate-induced neurotoxicity. Lancet 1995; 345: 544–547.
Drachtman RA, Cole PD, Golden CB, James SJ, Melnyk S, Aisner J et al. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol 2002; 19: 319–327.
Sandoval C, Kutscher M, Jayabose S, Tenner M . Neurotoxicity of intrathecal methotrexate: MR imaging findings. AJNR Am J Neuroradiol 2003; 24: 1887–1890.
Hill FG, Richards S, Gibson B, Hann I, Lilleyman J, Kinsey S et al. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). Br J Haematol 2004; 124: 33–46.
Peylan-Ramu N, Poplack DG, Pizzo PA, Adornato BT, Di CG . Abnormal CT scans of the brain in asymptomatic children with acute lymphocytic leukemia after prophylactic treatment of the central nervous system with radiation and intrathecal chemotherapy. N Engl J Med 1978; 298: 815–818.
Ahlemeyer B, Kolker S, Zhu Y, Hoffmann GF, Krieglstein J . Increase in glutamate-induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C. J Neurochem 2002; 82: 504–515.
Ahlemeyer B, Kolker S, Zhu Y, Hoffmann GF, Krieglstein J . Cytosine arabinofuranoside-induced activation of astrocytes increases the susceptibility of neurons to glutamate due to the release of soluble factors. Neurochem Int 2003; 42: 567–581.
Riccardi R, Riccardi A, Lasorella A, Servidei T, Mastrangelo S . Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia. Clin Cancer Res 1998; 4: 69–73.
Acknowledgements
Sue Richards and Rachel Clack of the Clinical Trial Service Unit (Oxford) coordinated questionnaire return and provided patient data. We would like to thank all the UK Children’s Cancer and Leukaemia Group centres for their participation in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bond, J., Hough, R., Moppett, J. et al. ‘Stroke-like syndrome’ caused by intrathecal methotrexate in patients treated during the UKALL 2003 trial. Leukemia 27, 954–956 (2013). https://doi.org/10.1038/leu.2012.328
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.328
- Springer Nature Limited
This article is cited by
-
Characteristics of methotrexate-induced stroke-like neurotoxicity
International Journal of Hematology (2018)
-
Methotrexate/cyclophosphamide/cytarabine
Reactions Weekly (2015)